Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 22, 2006
Reporting Period: Fourth Quarter and Twelve Months ended December 31, 2005
This filing announces the release of the Company's fourth quarter and full-year 2005 earnings results via an Investor News release (Exhibit 99.1). The filing serves to distribute these results to the SEC and includes non-GAAP financial measures to supplement GAAP reporting.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references the following metrics as being detailed in the attached Exhibit 99.1:
- GAAP consolidated financial results for Q4 and FY 2005.
- Non-GAAP measures including EBITDA (operating income excluding depreciation, amortization, and minority interests).
- Operating income excluding one-time costs.
- Free cash flow.
- Dialysis products external sales.
Note: Specific figures for these metrics are not present in the Form 6-K cover text and must be sourced from the attached Investor News.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It states that the non-GAAP measures are included to ensure consistency and comparability with prior periods for which these measures were previously reported.
Guidance, Outlook, and Risks
Management Commentary: Management asserts that the inclusion of non-GAAP measures enhances the user's understanding of current financial performance and future prospects. Reconciliations between non-GAAP and GAAP measures are provided in the attached Investor News and Cash Flow Statement.
Regulatory Note: The attached Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. It shall not be incorporated by reference in other filings.
Risks/Contingencies: No specific risks or contingencies are detailed in this cover text.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for specific Q4 and FY 2005 revenue, net income, and cash flow figures.
- Verify the reconciliation of non-GAAP measures (EBITDA, Free Cash Flow) to GAAP equivalents as required by Regulation G.
- Confirm the impact of one-time costs on operating income as disclosed in the full earnings release.
- Check for any forward-looking guidance or outlook statements contained within the attached Investor News.